Literature DB >> 29602327

Transdiagnostic internet-delivered cognitive-behaviour therapy (CBT) for adults with functional gastrointestinal disorders (FGID): A feasibility open trial.

B F Dear1, V J Fogliati2, R Fogliati2, M Gandy2, S McDonald2, N Talley3, G Holtmann4, N Titov2, M Jones5.   

Abstract

Many people with functional gastrointestinal disorders (FGIDs) face significant barriers in accessing psychological treatments that are known to reduce symptoms and their psychological sequelae. This study examined the feasibility and initial outcomes of a transdiagnostic and internet-delivered cognitive behaviour therapy (iCBT) intervention, the Chronic Conditions Course, for adults with functional gastrointestinal disorders (FGIDs). A single-group feasibility open trial design was employed and administered to twenty seven participants. The course ran for 8 weeks and was provided with weekly contact from a Clinical Psychologist. Seventy percent of participants completed the course within the 8 weeks and 81.5% provided data at post-treatment. High levels of satisfaction were observed and relatively little clinician time (M = 42.70 min per participant; SD = 46.25 min) was required. Evidence of clinical improvements in FGID symptoms (ds ≥ 0.46; avg. improvement ≥21%), anxiety symptoms (ds ≥ 0.99; avg. improvement ≥42%), and depression symptoms (ds ≥ 0.75; avg. improvement ≥35%) were observed, which either maintained or continued to improve to 3-month follow-up. Evidence of improvement was also observed in pain catastrophising and mental-health related quality of life, but not physical-health related quality of life. These findings highlight the potential value of transdiagnostic internet-delivered programs for adults with FGIDs and support for the conduct of larger-scale controlled studies.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29602327     DOI: 10.1016/j.jpsychores.2018.02.015

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  8 in total

1.  Transdiagnostic psychiatry: a systematic review.

Authors:  Paolo Fusar-Poli; Marco Solmi; Natascia Brondino; Cathy Davies; Chungil Chae; Pierluigi Politi; Stefan Borgwardt; Stephen M Lawrie; Josef Parnas; Philip McGuire
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

2.  Effects of a comprehensive self-management intervention on extraintestinal symptoms among patients with IBS.

Authors:  Kendra J Kamp; Kristen R Weaver; LeeAnne B Sherwin; Pamela Barney; Sun-Kyung Hwang; Pei-Lin Yang; Robert L Burr; Kevin C Cain; Margaret M Heitkemper
Journal:  J Psychosom Res       Date:  2019-08-29       Impact factor: 3.006

3.  Efficacy of internet-delivered cognitive behavioural therapy following an acute coronary event: A randomized controlled trial.

Authors:  L H Schneider; H D Hadjistavropoulos; B F Dear; N Titov
Journal:  Internet Interv       Date:  2020-05-07

4.  Transdiagnostic Cognitive-Behavioral Therapy for Depression and Anxiety Disorders in Cardiovascular Disease Patients: Results From the CHAMPS Pilot-Feasibility Trial.

Authors:  Phillip J Tully; Deborah A Turnbull; John D Horowitz; John F Beltrame; Bernhard T Baune; Shannon Sauer-Zavala; Harald Baumeister; Christopher G Bean; Ronette B Pinto; Suzie Cosh; Gary A Wittert
Journal:  Front Psychiatry       Date:  2022-04-14       Impact factor: 5.435

5.  A unified Internet-delivered exposure treatment for undifferentiated somatic symptom disorder: single-group prospective feasibility trial.

Authors:  Jonna Hybelius; Anton Gustavsson; Sandra Af Winklerfelt Hammarberg; Eva Toth-Pal; Robert Johansson; Brjánn Ljótsson; Erland Axelsson
Journal:  Pilot Feasibility Stud       Date:  2022-07-19

6.  Internet-delivered cognitive behaviour therapy for chronic health conditions: self-guided versus team-guided.

Authors:  S H Mehta; M Nugent; V Peynenburg; D Thiessen; G La Posta; N Titov; B F Dear; H D Hadjistavropoulos
Journal:  J Behav Med       Date:  2022-08-03

7.  Application of unified protocol as a transdiagnostic treatment for emotional disorders during COVID-19: An internet-delivered randomized controlled trial.

Authors:  Kou Yan; Mohammad Hassan Yusufi; Nabi Nazari
Journal:  World J Clin Cases       Date:  2022-08-26       Impact factor: 1.534

Review 8.  "It ain't over … till it's over!" Risk-mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID-19 pandemic.

Authors:  Gerald Holtmann; Eamonn M Quigley; Ayesha Shah; Michael Camilleri; Victoria Py Tan; Kok Ann Gwee; Kentaro Sugano; Jose D Sollano; Kwong M Fock; Uday C Ghoshal; Minhu Chen; Axel Dignass; Henry Cohen
Journal:  J Gastroenterol Hepatol       Date:  2020-06-29       Impact factor: 4.369

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.